FTFlorence Thirion

Florence Thirion

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Florence Thirion has a total of 162 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fecal extracellular vesicles from adults with autism spectrum disorder affect mouse behavior and gut motility by targeting the neuronal nitrergic pathway

    by Baptiste Ganachaud, Irem Buruk, Catherine Le Berre-Scoul, Philippe Aubert, Camille Trottier, Néfis Djelassi, Mathéus Moreau, Florian Petrilli, Jean-Romain Richard, Camille Dupuy, et al.

    In addition to behavioral symptoms, many patients with autism spectrum disorder (ASD) experience gastrointestinal disorders associated with gut microbiota dysbiosis. In order to better understand the mechanisms underlying microbiota-gut-brain interactions in ASD, we isolated fecal extracellular vesicles (EVs), as a source of microbiota-derived EVs, from control individuals (f-EV-CTL) and patients with ASD (f-EV-ASD) to study in mice their effects on the brain and gut. The f-EV-ASD induced increased sociability and anxiolytic-like behavior, and reduced gastrointestinal transit time compared to mice treated with f-EV-CTL. In the colon, f-EV-ASD altered motility through the enteric neuronal nitric oxide (NO)-sensitive component. f-EV-ASD potentiated NO signaling and disrupted intracellular calcium dynamics in enteric neurons. This effect was modulated through a mechanism consistent with FFAR3 receptor involvement. Our findings suggest that fecal EVs may act as mediators of microbiota-host communication, linking microbial metabolites to altered behavior and gut function and identifying a potential mechanism relevant to ASD pathophysiology.

  • Open Access

    Lactiplantibacillus plantarum WJL ameliorates chronic kidney disease by inhibiting fibroblast growth factor 21 adaptive stress response via low protein diet

    by Berengère Benoit, Pierre Letourneau, Vincent Verdier, Angélique Viney, Cécile Barnel, Karim Chikh, Oriane Vitalis, Audrey Jalabert, Sandra Wagner, Manolo Laiola, et al.

    Chronic kidney disease (CKD) is projected to become the fifth leading cause of death by 2040, underscoring the urgency of early interventions to slow its progression. 1 When kidney function decline...

  • Open Access

    Increasing plant protein sources in the diet modulates gut microbiota and tryptophan metabolism in men at cardiometabolic risk

    by Gaïa Lépine, Anne-Marie Davila, Gwendal Cueff, Gisèle Pickering, Farid Ichou, Caroline Perreau, Catherine Lefranc-Millot, Marine Gilles, Florence Thirion, François Mariotti, et al.

    Western dietary patterns, characterized by high intakes of red and processed meat, saturated fat, and refined carbohydrates, contribute substantially to the global burden of cardiometabolic disease...


  • Open Access

    Short-chain fructo-oligosaccharides modulate gut microbiota composition and metabolism: dose–response assessment in an ex vivo gut model

    by Christelle Bressuire, Florence Thirion, Laura Chiaravano, Serigne Inssa Ngom, Romane Marion, Marine Gilles, Benoît Quinquis, Elliot Mathieu, Magali Berland, Hervé M. Blottière, et al.

    Short-chain fructo-oligosaccharides (scFOS) are prebiotic fiber rapidly fermented in the colon and known to stimulate beneficial bacteria, such as Bifidobacterium spp. and Lactobacillaceae. While their overall effects on the gut microbiota are established, the dose–response relationship remained only partially characterized. This study aimed to determine the minimum effective dose of scFOS required to modulate gut microbiota composition and functions. An ex vivo chemostat model was used to simulate colonic fermentation with different doses of scFOS (1 to 10 g/d). Microbiota composition and metabolic activity were assessed by qPCR, short-chain fatty acid (SCFA) quantification, and shotgun metagenomics. An increase in scFOS dose led to higher SCFA levels, particularly acetate and butyrate, along with a modification in microbial composition, with a minimum significant effective dose of 2.5 g/d. Significant increase in Bifidobacterium adolescentis, Anaerostipes hadrus, and Clostridium innocuum was observed at the same dose. Functional analysis revealed an enrichment of GH32 genes in the pangenomes of species positively impacted by scFOS. These findings demonstrate that low doses of scFOS can effectively modulate the gut microbiota and enhance SCFA production, supporting their use in dietary interventions aimed at improving intestinal health.

  • Top Cited Papers
    Open Access

    Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-Microbiome Study

    by Manolo Laiola, Laetitia Koppe, Amine Larabi, Florence Thirion, Céline Lange, Benoit Quinquis, Aymeric David, Emmanuelle Le Chatelier, Berengere Benoit, Giuseppina Sequino, et al.

    Background: The gut microbiota has been linked to non-communicable diseases, including chronic kidney disease (CKD). However, the relationships between gut microbiome composition changes, uraemic toxins (UTs) accumulation, and diet on CKD severity and progression remain underexplored. Objective: To characterise relationships between gut microbiome composition and functionality, UTs diet, and CKD severity and progression, as well as assess microbial contributions to UTs accumulation through mice faecal microbiota transplantation (FMT). Design: This study profiled the gut microbiome of 240 non-dialysis patients with CKD (CKD-REIN cohort) using shotgun metagenomics, with follow-up in 103 patients after 3 years, with comparisons with healthy volunteers from the Milieu Intérieur cohort. A multiomics approach identifies features associated with CKD severity (and progression), with validation in an independent Belgian cohort. Experimental models used FMT to test CKD gut microbiome effects on UTs and kidney fibrosis. Changes in gut microbiome over time were evaluated, and the impact of diet on these changes was assessed. Results: Compared with matched healthy controls, patients with CKD exhibited gut microbiota alteration, with enrichment of UT precursor-producing species. Patients with severe CKD exhibited higher UT levels and greater enrichment of UT (precursor)-producing species in the microbiota than patients with moderate CKD. Over time, UT (precursor)-producing species increased, and a plant-based low protein diet appeared to mitigate these changes. FMT from patients with CKD to antibiotic-treated CKD model mice increased serum UT levels and exacerbated kidney fibrosis. Conclusions: This study highlights the role of the microbiome and UTs in CKD, suggesting a potential therapeutic target to slow disease progression.


  • Évolution du microbiote intestinal sous brodalumab au cours du psoriasis en plaques

    by A. Villani, F. Thirion, N. Quiles-Tsimaratos, B. Quinquis, M.G. Thiam, A. Khemis, S. Gilibert, C. Goujon-Henry, F. Skowron, T. Boyé, et al.

  • Open Access

    Cross talk between Paneth and tuft cells drives dysbiosis and inflammation in the gut mucosa

    by Nathalie Coutry, Julie Nguyen, Salima Soualhi, François Gerbe, Victoria Meslier, Valérie Dardalhon, Mathieu Almeida, Benoit Quinquis, Florence Thirion, Fabien Herbert, et al.

    Gut microbiota imbalance (dysbiosis) is increasingly associated with pathological conditions, both within and outside the gastrointestinal tract. Intestinal Paneth cells are considered to be guardians of the gut microbiota, but the events linking Paneth cell dysfunction with dysbiosis remain unclear. We report a three-step mechanism for dysbiosis initiation. Initial alterations in Paneth cells, as frequently observed in obese and inflammatorybowel diseases patients, cause a mild remodeling of microbiota, with amplification of succinate-producing species. SucnR1-dependent activation of epithelial tuft cells triggers a type 2 immune response that, in turn, aggravates the Paneth cell defaults, promoting dysbiosis and chronic inflammation. We thus reveal a function of tuft cells in promoting dysbiosis following Paneth cell deficiency and an unappreciated essential role of Paneth cells in maintaining a balanced microbiota to prevent inappropriate activation of tuft cells and deleterious dysbiosis. This succinate–tuft cell inflammation circuit may also contribute to the chronic dysbiosis observed in patients.


  • Top Cited Papers
    Open Access

    The gut microbiota contributes to the pathogenesis of anorexia nervosa in humans and mice

    by Yong Fan, René Klinkby Støving, Samar Berreira Ibraim, Tuulia Hyötyläinen, Florence Thirion, Tulika Arora, Liwei Lyu, Evelina Stankevic, Tue Haldor Hansen, Pierre Déchelotte, et al.

    Anorexia nervosa (AN) is an eating disorder with a high mortality. About 95% of cases are women and it has a population prevalence of about 1%, but evidence-based treatment is lacking. The pathogenesis of AN probably involves genetics and various environmental factors, and an altered gut microbiota has been observed in individuals with AN using amplicon sequencing and relatively small cohorts. Here we investigated whether a disrupted gut microbiota contributes to AN pathogenesis. Shotgun metagenomics and metabolomics were performed on faecal and serum samples, respectively, from a cohort of 77 females with AN and 70 healthy females. Multiple bacterial taxa (for example,Clostridiumspecies) were altered in AN and correlated with estimates of eating behaviour and mental health. The gut virome was also altered in AN including a reduction in viral–bacterial interactions. Bacterial functional modules associated with the degradation of neurotransmitters were enriched in AN and various structural variants in bacteria were linked to metabolic features of AN. Serum metabolomics revealed an increase in metabolites associated with reduced food intake (for example, indole-3-propionic acid). Causal inference analyses implied that serum bacterial metabolites are potentially mediating the impact of an altered gut microbiota on AN behaviour. Further, we performed faecal microbiota transplantation from AN cases to germ-free mice under energy-restricted feeding to mirror AN eating behaviour. We found that the reduced weight gain and induced hypothalamic and adipose tissue gene expression were related to aberrant energy metabolism and eating behaviour. Our ‘omics’ and mechanistic studies imply that a disruptive gut microbiome may contribute to AN pathogenesis.


  • Open Access

    Alteration of Gut Microbiome in Patients With Schizophrenia Indicates Links Between Bacterial Tyrosine Biosynthesis and Cognitive Dysfunction

    by Florence Thirion, Helene Speyer, Tue Haldor Hansen, Trine Nielsen, Yong Fan, Emmanuelle Le Chatelier, Sébastien Fromentin, Magali Berland, Florian Plaza Oñate, Nicolas Pons, et al.